EKO International (OTCPK:EKNL) - Stock Price, News & Analysis

EKNL Stock Overview

Through its joint venture interest in NeuroVasc Clinical Inc., promotes and distributes frequency rhythmic electrical modulation system equipment used in the treatment of peripheral neuropathy in Canada. More details

EKNL fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Latest financial reports are more than a year old

Shares are highly illiquid

Does not have a meaningful market cap ($316)

EKO International Corp. Competitors

NAPC Defense

OTCPK:BLIS

US$2.0m

E Automotive

OTCPK:EICC.F

US$4.8m

Sentage Holdings

NasdaqCM:SNTG

US$5.4m

Inscape

OTCPK:ICPB.Q

US$143.8k

Price History & Performance

Summary of all time highs, changes and price drops for EKO International
Historical stock prices
Current Share Price	US$0.00001
52 Week High	US$0.0002
52 Week Low	US$0.00001
Beta	0
11 Month Change	0%
3 Month Change	n/a
1 Year Change	n/a
33 Year Change	-99.91%
5 Year Change	-99.50%
Change since IPO	-100.00%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	EKNL	US Commercial Services	US Market
7D	0%	4.0%	2.2%
1Y	n/a	36.9%	31.6%

Return vs Industry: Insufficient data to determine how EKNL performed against the US Commercial Services industry.

Return vs Market: Insufficient data to determine how EKNL performed against the US Market.

Price Volatility

Is EKNL's price volatile compared to industry and market?
EKNL volatility
EKNL Average Weekly Movement	n/a
Commercial Services Industry Average Movement	7.4%
Market Average Movement	6.3%
10% most volatile stocks in US Market	15.7%
10% least volatile stocks in US Market	3.1%

Stable Share Price: EKNL has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine EKNL's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
n/a	n/a	n/a	n/a

EKO International Corp., through its joint venture interest in NeuroVasc Clinical Inc., promotes and distributes frequency rhythmic electrical modulation system equipment used in the treatment of peripheral neuropathy in Canada. The company, through its joint venture interest in NeuroVasc Clinical Inc., also sets up and/or manage clinics to treat patients using FREMSTM equipment. EKO International Corp. is based in Burlington, Canada.

EKO International Corp. Fundamentals Summary

How do EKO International's earnings and revenue compare to its market cap?
EKNL fundamental statistics
Market cap	US$316.00
Earnings (TTM)	US$30.88k
Revenue (TTM)	n/a

0.0x

P/E Ratio

0.0x

P/S Ratio

Is EKNL overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
EKNL income statement (TTM)
Revenue	-US$970.19k
Cost of Revenue	-US$431.59k
Gross Profit	-US$538.60k
Other Expenses	-US$569.48k
Earnings	US$30.88k

Last Reported Earnings

Mar 31, 2011

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did EKNL perform over the long term?

See historical performance and comparison